Medsafe Pharmaceuticals Private Limited, a active private limited company, was established on 13 June 2016 in Panvel, Maharashtra, India. Engaging in medical equipment retail & distribution within the healthcare sector, it holds CIN: U33130MH2016PTC282293. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.13 M.
It upholds a compliant status. Its leadership includes Senbhadra Thakur (Director), Bindu Senbhadra Thakur (Director). Past directors included Sharad Jangam Shankar. It holds ₹1.80 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shop No. 05, Ground Floor, A Wing, Swara Symphony, Plot No. A-22, A-23 & A-24, Village Devad, Panvel, Maharashtra, 410206.
U33130MH2016PTC282293
282293
13 June 2016
₹1.50 M
₹1.13 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Medsafe Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Senbhadra Thakur | Director | 13 Jun 2016 | Current |
| Bindu Senbhadra Thakur | Director | 27 Mar 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Mar 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medsafe Pharmaceuticals Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 1057.46% increase. The company also saw a substantial improvement in profitability, with a 175.66% increase in profit. The company's net worth Soared by an impressive increase of 205.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Medsafe Pharmaceuticals had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jun 2020 | Others | ₹0.30 M | Open |
| 28 Jul 2017 | Others | ₹1.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medsafe Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medsafe Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medsafe Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medsafe Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Medsafe Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Progress on A charge with Others amounted to Rs. 0.30 M with Charge ID 100342349 was registered on 05 Jun 2020. was documented.
Progress on A charge with Others amounted to Rs. 1.50 M with Charge ID 100116055 was registered on 28 Jul 2017. was documented.
The activity Bindu Senbhadra Thakur was appointed as a Director was appointed as a Director on 27 Mar 2017 & has been associated with this company since 8 years 8 months . was completed.
Progress on Senbhadra Thakur was appointed as a Director was appointed as a Director on 13 Jun 2016 & has been associated with this company since 9 years 6 months . was documented.
The CIN of Medsafe Pharmaceuticals Private Limited is U33130MH2016PTC282293.
Medsafe Pharmaceuticals Private Limited is headquartered at Shop No. 05, Ground Floor, A Wing, Swara Symphony, Plot No. A-22, A-23 & A-24, Village Devad, Panvel, Maharashtra, 410206.
Medsafe Pharmaceuticals Private Limited was incorporated on 13 June 2016.
The current directors of Medsafe Pharmaceuticals Private Limited are
The primary industry of Medsafe Pharmaceuticals Private Limited is Healthcare.
Medsafe Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medsafe Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.13 M.
The compliance status of Medsafe Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX